The EML4-ALK fusion protein mediates reduced sensitivity to the combination of neratinib and dasatinib

被引：0
|
作者：
Castel, Myra E.
Conlon, Neil T.
Eli, Lisa D.
Wong, Alvin
Crown, John
Collins, Denis M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4041
引用
收藏
页数：2
相关论文
共 50 条
  • [31] EML4-ALK in NSCLC: The OSU Experience
    Bertino, E. M.
    Zhao, W.
    Villalona-Calero, M. A.
    Karim, N. F. Abdel
    Shilo, K.
    Otterson, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Pulmonary Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene
    Sokai, Akihiko
    Enaka, Makiko
    Sokai, Risa
    Mori, Shoichi
    Mori, Shunsuke
    Gunji, Masaharu
    Fujino, Masahiko
    Ito, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 93 - 96
  • [33] EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
    Inamura, Kentaro
    Takeuchi, Kengo
    Togashi, Yuki
    Nomura, Kimie
    Ninomiya, Hironori
    Okui, Michiyo
    Satoh, Yukitoshi
    Okumura, Sakae
    Nakagawa, Ken
    Soda, Manabu
    Choi, Young Lim
    Niki, Toshiro
    Mano, Hiroyuki
    Ishikawa, Yuichi
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) : 13 - 17
  • [34] A RARE CASE OF PEDIATRIC SPINDLE CELL ONCOCYTOMA WITH EML4-ALK FUSION
    Michaiel, George
    Hawes, Debra
    Guzman, Samuel
    Margol, Ashley
    Biegel, Jaclyn
    Ji, Jianling
    NEURO-ONCOLOGY, 2021, 23 : 45 - 45
  • [35] CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma
    An, Rong
    Wang, Yisong
    Voeller, Donna
    Gower, Arjan
    Kim, In-Kyu
    Zhang, Yu-Wen
    Giaccone, Giuseppe
    ONCOTARGET, 2016, 7 (20) : 29199 - 29210
  • [36] Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
    Takeuchi, Kengo
    Choi, Young Lim
    Soda, Manabu
    Inamura, Kentaro
    Togashi, Yuki
    Hatano, Satoko
    Enomoto, Munehiro
    Takada, Shuji
    Yamashita, Yoshihiro
    Satoh, Yukitoshi
    Okumura, Sakae
    Nakagawa, Ken
    Ishikawa, Yuichi
    Mano, Hiroyuki
    CLINICAL CANCER RESEARCH, 2008, 14 (20) : 6618 - 6624
  • [37] A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
    Tanaka, Hisashi
    Hayashi, Akihito
    Morimoto, Takeshi
    Taima, Kageaki
    Tanaka, Yoshihito
    Shimada, Michiko
    Kurose, Akira
    Takanashi, Shingo
    Okumura, Ken
    BMC CANCER, 2012, 12
  • [38] Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene
    Fukui, Takayuki
    Yatabe, Yasushi
    Kobayashi, Yoshihisa
    Tomizawa, Kenji
    Ito, Simon
    Hatooka, Shunzo
    Matsuo, Keitaro
    Mitsudomi, Tetsuya
    LUNG CANCER, 2012, 77 (02) : 319 - 325
  • [39] EML4-ALK fusion variants associate with gender and age in Chinese NSCLC patients
    Zhao, W.
    Liang, G.
    Wang, L.
    Dai, L.
    Wu, D.
    Wang, K.
    Wang, A.
    Chen, H.
    Dong, Y-A.
    Wang, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 43 - 43
  • [40] HS-AFM imaging the dynamic structure of EML4-ALK fusion oncoproteins
    Han, Xujun
    Kodera, Noriyuki
    Matsumoto, Kunio
    Yano, Seiji
    CANCER SCIENCE, 2023, 114 : 988 - 988
12345